Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Ionis Pharmaceuticals, Inc. (IONS) had Profit Margin of -42.79% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$267.95M |
|
$-114.65M |
|
$2.74M |
|
$265.21M |
|
$370.24M |
|
$-102.29M |
|
$-11.09M |
|
$-113.38M |
|
$-103.20M |
|
$-114.65M |
|
$-114.65M |
|
$-114.65M |
|
$-104.58M |
|
$-102.29M |
|
$-96.20M |
|
165.42M |
|
165.42M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$2.49B |
|
$155.13M |
|
$503.23M |
|
$2.99B |
|
$315.64M |
|
$1.35B |
|
$2.24B |
|
$2.55B |
|
$439.74M |
|
$439.74M |
|
$439.74M |
|
165.64M |
|
| Cash Flow Statement Financials | |
$-227.29M |
|
$560.32M |
|
$-355.04M |
|
$372.26M |
|
$350.06M |
|
$-22.20M |
|
$88.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.89 |
|
-- |
|
-- |
|
0.75 |
|
3.07 |
|
98.98% |
|
-38.18% |
|
-38.18% |
|
-- |
|
-42.31% |
|
|
Profit Margin |
-42.79% |
$-265.13M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.05 |
|
4.55 |
|
19.77 |
|
-26.07% |
|
-26.07% |
|
-3.83% |
|
-6.40% |
|
$2.65 |
|
$-1.60 |
|
$-1.37 |
|